KalVista Pharmaceuticals, Inc.

KALVDelisted Jun 11, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001348911

SEC filings (opens in a new tab)

KalVista Pharmaceuticals, Inc. was delisted on Jun 11, 2026; its insiders filed their last Form 4 on Jun 11, 2026; 184 institutions reported holding it in 13F filings for Q1 2026, worth $1.39B in total; no superinvestor held it.

Q4 2025 vs. Q3 2025

How the institutions holding KalVista Pharmaceuticals, Inc. changed between Q3 2025 and Q4 2025.

All holders in Q4 2025 All holders in Q3 2025

13F holders of KALV: Q3 2025 compared with Q4 2025
Measure	Q3 2025	Of which not filed for Q4 2025	Q4 2025	Change
Holders	145	1	162	+18
Shares	58.6M	31.2K	67.0M	+8.37M (+14.3%)
Value	$714.0M	$380.2K	$1.08B	+$367.7M (+51.5%)

1 institution that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (37)

Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to KALV in Q4 2025
Institution	Shares	Value	% of portfolio
Point72 Asset Management, L.P.	2,283,766	$36.9M	0.06%
Elmind Capital, LP	801,300	$12.9M	3.82%
Armistice Capital, LLC	800,000	$12.9M	0.32%
Squadron Capital Management LLC	700,000	$11.3M	5.04%
Great Point Partners LLC	685,632	$11.1M	3.59%
Spruce Street Capital LP	387,968	$6.27M	2.07%
OrbiMed Advisors LLC	382,400	$6.18M	0.13%
HRT Financial LP	287,052	$4.63M	0.01%
Atom Investors LP	276,113	$4.46M	0.35%
Renaissance Technologies LLC	165,151	$2.67M	0.00%
NEXTBio Capital Management LP	131,796	$2.13M	1.25%
Jump Financial, LLC	90,742	$1.47M	0.02%
Seven Fleet Capital Management LP	48,412	$781.9K	0.53%
Alps Advisors Inc	41,504	$670.3K	0.00%
Citadel Advisors LLC	37,761	$609.8K	0.00%
Ikarian Capital, LLC	35,119	$567.2K	0.07%
Martingale Asset Management L P	30,939	$499.7K	0.01%
XTX Topco Ltd	26,508	$428.1K	0.01%
Aquatic Capital Management LLC	23,370	$377.4K	0.01%
ExodusPoint Capital Management, LP	20,061	$324.0K	0.00%
Man Group plc	17,446	$281.8K	0.00%
Bleakley Financial Group, LLC	15,976	$258.0K	0.00%
Algert Global LLC	13,110	$211.7K	0.00%
Diversified Trust Co	10,870	$175.6K	0.00%
Cerro Pacific Wealth Advisors LLC	10,000	$161.5K	0.04%
Group One Trading, L.P.	3,777	$61.0K	0.00%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	613	$10.0K	0.00%
Aster Capital Management (DIFC) Ltd	278	$4.49K	0.00%
Garner Asset Management Corp	135	$2.18K	0.00%
Rockefeller Capital Management L.P.	133	$2.15K	0.00%
Torren Management, LLC	119	$1.92K	0.00%
Federated Hermes, Inc.	75	$1.21K	0.00%
Fortitude Family Office, LLC	60	$969	0.00%
UMA Financial Services, Inc.	45	$727	0.00%
Clearstead Advisors, LLC	38	$618	0.00%
Stone House Investment Management, LLC	14	$226	0.00%
Hughes Financial Services, LLC	1	$16	0.00%

Sold out (19)

Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.

Institutions that sold out of KALV in Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
Sio Capital Management, LLC	683,819	$8.33M
Marshall Wace, LLP	370,773	$4.52M
Qube Research & Technologies Ltd	325,435	$3.96M
Jefferies Financial Group Inc.	286,875	$3.49M
SummitTX Capital, L.P.	143,561	$1.75M
Susquehanna Portfolio Strategies, LLC	128,011	$1.56M
Boothbay Fund Management, LLC	107,283	$1.31M
StemPoint Capital LP	56,770	$691.5K
Dimensional Fund Advisors LP	45,444	$553.5K
Artia Global Partners LP	41,555	$506.1K
Capstone Investment Advisors, LLC	21,421	$260.9K
D. E. Shaw & Co., Inc.	21,100	$257.0K
Axq Capital, LP	17,213	$209.7K
DRW Securities, LLC	16,775	$196.0K
Susquehanna Fundamental Investments, LLC	10,686	$130.2K
Wolverine Asset Management LLC	4,662	$56.8K
CIBC Private Wealth Group, LLC	160	$1.95K
CoreCap Advisors, LLC	23	$280
IFP Advisors, Inc	5	$61

Not filed for Q4 2025 yet (1)

Institutions that held KalVista Pharmaceuticals, Inc. at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding KALV in Q3 2025 that haven't filed for Q4 2025
Institution	Shares, Q3 2025	Value, Q3 2025
HAP Trading, LLC	31,219	$380.2K